marginally significantp = 0.056
Subgroup analysis showed that Ad-CMV-hsFlt-1-e15a led to a significant increase in albumin/creatinine ratio on PPD8 (3-fold, p = 0.003); Ad-RGD-CMV-hsFlt-1-e15a led to significant increase in albumin/creatinine ratio on GD18 (2.4-fold, p = 0.04); while Ad-RGD-CYP-hsFlt-1-e15a led to a marginally significant increase in albumin/creatinine ratio on GD18 (2.4-fold, p = 0.056) and a significant increase on PPD8 (1.8-fold, p = 0.04) ( Figure 7B ).